Singapore Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports

Singapore Pharmaceuticals and Healthcare Report

Singapore Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports
Singapore Pharmaceuticals and Healthcare Report
Published Jun 11, 2016
106 pages — Published Jun 11, 2016
Price US$ 1,295.00  |  Buy this Report Now

About This Report

  
Abstract:

That same month, National University Hospital will be undertaking a study involving --- people with normal blood sugar levels and -,--- pre-diabetics. This is funded both by the Ministry of Health and Janssen Pharmaceuticals and seeks to identify lifestyle as well as biomarkers that makes a patient more likely to develop diabetes. ...That same month, National University Hospital will be undertaking a study involving --- people with normal blood sugar levels and -,--- pre-diabetics. This is funded both by the Ministry of Health and Janssen Pharmaceuticals and seeks to identify lifestyle as well as biomarkers that makes a patient more likely to develop diabetes. A separate study published in May ---- noted that the aggregate, direct and indirect cost of dementia in Singapore amounted to SGD-.-bn annually. ...A separate study published in May ---- noted that the aggregate, direct and indirect cost of dementia in Singapore amounted to SGD-.-bn annually. In ----, the country shouldered a cost of SGD---mn to care for people with brain disease marked by memory disorders, personality changes and impaired reasoning.

...Increasing potential of export sector, boosted by multinational presence and the country s growing status as a regional R&D and manufacturing base. ...Increasing potential of export sector, boosted by multinational presence and the country s growing status as a regional R&D and manufacturing base. Better import export balance, allowing greater re-investment in market development in medium and long term. Tax breaks offered to drugmakers in exchange for increase in local production capacity. Expansion of the elderly and disabled care programme to boost demand for treatments of chronic diseases.

...All information contained in this publication is copyrighted in the name of Business Monitor International Ltd, and as such no part of this publication may be reproduced, repackaged, redistributed, resold in whole or in any part, or used in any form or by any means graphic, electronic or mechanical, including photocopying, recording, taping, or by information storage or retrieval, or by any other means, without the express written consent of the publisher. ...

...Strengths Strong intellectual property protection laws. Highly educated workforce, stable government and economy. ...

  
Source:
Document ID
1748-216X
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Business Monitor International - Industry Reports—Established in 1984, Business Monitor International is a leading online publisher of specialist business information on global emerging markets. Business Monitor's range of quarterly services covers political risk, finance, macroeconomic performance, outlook and forecast, industry sectors and the business operating environment. Each Industry Report has been researched at source, and features latest-available data covering production, sales, imports and exports; 5-year industry forecasts through end-2012; company rankings and competitive landscapes for multinational and local manufacturers and suppliers; and analysis of latest industry developments, trends and regulatory changes.

About the Author


Cite this Report

  
MLA:
Business Monitor International - Industry Reports. "Singapore Pharmaceuticals and Healthcare Report" Jun 11, 2016. Alacra Store. Dec 06, 2016. <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Singapore-Pharmaceuticals-and-Healthcare-Report-2026-120>
  
APA:
Business Monitor International - Industry Reports. (2016). Singapore Pharmaceuticals and Healthcare Report Jun 11, 2016. New York, NY: Alacra Store. Retrieved Dec 06, 2016 from <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Singapore-Pharmaceuticals-and-Healthcare-Report-2026-120>
  
US$ 1,295.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.